Thus, a demonstration of H19 lncRNA function and an identification of H19-CUL4A-ABCB1/MDR1 pathway in chemoresistance have shed new light to the understanding of chemoresistance and will provide new therapeutic targets and strategies for clinical management of breast cancer patients. The gene discussed is CUL4A; the disease is breast carcinoma.